444
Views
5
CrossRef citations to date
0
Altmetric
Author's View

Potential utility of the pan-Bcl-2 inhibitor GX15–070 (obatoclax) in cancer immunotherapy

&
Article: e29351 | Received 21 May 2014, Accepted 23 May 2014, Published online: 25 Jun 2014

Figures & data

Figure 1. The effect of the pan-Bcl-2 inhibitor GX15 on subsets of human T cells. (A) T-cell subsets in peripheral blood showed differential sensitivity to GX15 based on their activation, memory, and proliferative status. (B) GX15 preferentially reduced the proportion of Tregs in peripheral blood and altered their phenotype and function, potentially tipping the balance of immune cells toward effector memory T cells in the human tumor microenvironment.

Figure 1. The effect of the pan-Bcl-2 inhibitor GX15 on subsets of human T cells. (A) T-cell subsets in peripheral blood showed differential sensitivity to GX15 based on their activation, memory, and proliferative status. (B) GX15 preferentially reduced the proportion of Tregs in peripheral blood and altered their phenotype and function, potentially tipping the balance of immune cells toward effector memory T cells in the human tumor microenvironment.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.